Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

drawing of magnifying glass on a brain
Biotech

J&J-backed Delix secures $100M for non-hallucinatory psychedelic

Delix raised $100 million in a series C round backed by the likes of J&J to advance a phase 2-ready non-hallucinatory psychedelic for depression.
Marissa Russo Nov 9, 2026 10:30am
Boehringer Ingelheim Boehringer

AHA: Boehringer plans 2027 survodutide submission after CV win

Nov 9, 2026 9:45am
Podcast
Top Line Podcast - ZS

Use Kidney Genetics to Strengthen Clinical Trial Design

Brought to you by Natera
rocketship new blast off start up business development break off acquisition split

Spruce spins out preclinical endocrinology program into Adrenyx

Nov 9, 2026 9:30am
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
Goal disorientation and lack of vision

Zura scraps hidradenitis suppurativa program after phase 2 miss

Nov 9, 2026 9:21am